Yuan K, Tang Y, Ding Z, Peng L, Zeng J, Wu H
Front Mol Biosci. 2024; 11:1434398.
PMID: 39479502
PMC: 11521912.
DOI: 10.3389/fmolb.2024.1434398.
Wang B, Kou H, Wang Y, Zhang Q, Jiang D, Wang J
Cell Death Dis. 2024; 15(10):761.
PMID: 39426946
PMC: 11490576.
DOI: 10.1038/s41419-024-07116-4.
Denu R, Dann A, Keung E, Nakazawa M, Nassif Haddad E
Cancers (Basel). 2024; 16(5).
PMID: 38473300
PMC: 10930698.
DOI: 10.3390/cancers16050938.
Djos A, Thombare K, Vaid R, Gaarder J, Umapathy G, Reinsbach S
Cancers (Basel). 2023; 15(24).
PMID: 38136279
PMC: 10741428.
DOI: 10.3390/cancers15245732.
Li Y, Meng X, Luo Y, Huang X, Luo S, Wang J
Int J Anal Chem. 2023; 2023:7436368.
PMID: 37810911
PMC: 10555499.
DOI: 10.1155/2023/7436368.
Liquid biopsy: creating opportunities in brain space.
Trivedi R, Bhat K
Br J Cancer. 2023; 129(11):1727-1746.
PMID: 37752289
PMC: 10667495.
DOI: 10.1038/s41416-023-02446-0.
Impacts of radiation exposure, hindlimb unloading, and recovery on murine skeletal muscle cell telomere length.
Tichy E, Lee J, Li G, Estep K, Johnson F, Mourkioti F
NPJ Microgravity. 2023; 9(1):76.
PMID: 37714858
PMC: 10504369.
DOI: 10.1038/s41526-023-00303-1.
Alternative Lengthening of Telomeres Is Rare in Canine Histiocytic Sarcoma.
Kreilmeier-Berger T, Aupperle-Lellbach H, Reifinger M, Horstke N, Holzmann K, Kleiter M
Cancers (Basel). 2023; 15(17).
PMID: 37686490
PMC: 10487132.
DOI: 10.3390/cancers15174214.
Potential effects of assisted reproductive technology on telomere length and telomerase activity in human oocytes and early embryos.
Tire B, Ozturk S
J Ovarian Res. 2023; 16(1):130.
PMID: 37400833
PMC: 10318791.
DOI: 10.1186/s13048-023-01211-4.
Generation of an Obese Diabetic Mouse Model upon Conditional Disruption.
Gaspar T, Jesus T, Azevedo M, Macedo S, Soares M, Martins R
Cancers (Basel). 2023; 15(11).
PMID: 37296979
PMC: 10252256.
DOI: 10.3390/cancers15113018.
Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma.
Ocasio J, Budd K, Roach J, Andrews J, Baker S
Cancer Metastasis Rev. 2023; 42(2):367-388.
PMID: 37119408
PMC: 10441521.
DOI: 10.1007/s10555-023-10105-2.
Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT).
Sun H, Chen G, Guo B, Lv S, Yuan G
J Cancer. 2023; 14(3):417-433.
PMID: 36860927
PMC: 9969575.
DOI: 10.7150/jca.80097.
Cell Immortalization: In Vivo Molecular Bases and In Vitro Techniques for Obtention.
de Bardet J, Ramirez Cardentey C, Gonzalez B, Patrone D, Mulet I, Siniscalco D
BioTech (Basel). 2023; 12(1).
PMID: 36810441
PMC: 9944833.
DOI: 10.3390/biotech12010014.
Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma.
Harold J, Bellone S, Manavella D, Mutlu L, McNamara B, Hartwich T
Gynecol Oncol. 2022; 168:157-165.
PMID: 36442427
PMC: 9797429.
DOI: 10.1016/j.ygyno.2022.11.014.
ATRX modulates the escape from a telomere crisis.
Geiller H, Harvey A, Jones R, Grimstead J, Cleal K, Hendrickson E
PLoS Genet. 2022; 18(11):e1010485.
PMID: 36350851
PMC: 9678338.
DOI: 10.1371/journal.pgen.1010485.
Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour.
Gaspar T, Macedo S, Sa A, Soares M, Rodrigues D, Sousa M
Cancers (Basel). 2022; 14(16).
PMID: 36010860
PMC: 9406167.
DOI: 10.3390/cancers14163865.
Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis.
Bremer S, Bittner G, Elakad O, Dinter H, Gaedcke J, Konig A
Cancers (Basel). 2022; 14(12).
PMID: 35740494
PMC: 9221317.
DOI: 10.3390/cancers14122828.
ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors.
Pladevall-Morera D, Castejon-Grinan M, Aguilera P, Gaardahl K, Ingham A, Brosnan-Cashman J
Cancers (Basel). 2022; 14(7).
PMID: 35406561
PMC: 8997088.
DOI: 10.3390/cancers14071790.
Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression.
Hemming M, Bhola P, Loycano M, Anderson J, Taddei M, Doyle L
Clin Cancer Res. 2022; 28(11):2397-2408.
PMID: 35325095
PMC: 9167705.
DOI: 10.1158/1078-0432.CCR-21-3523.
Regulation of Replication Stress in Alternative Lengthening of Telomeres by Fanconi Anaemia Protein.
Li D, Hou K, Zhang K, Jia S
Genes (Basel). 2022; 13(2).
PMID: 35205225
PMC: 8872277.
DOI: 10.3390/genes13020180.